Cancer: Metastasis risk after anti-macrophage therapy

Nature

Volumn 515, Issue 7525, 2014, Pages 46-47

  Keklikoglou, Ioanna ^a   De Palma, Michele ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1 INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

CANCER; DISEASE TREATMENT; IMMUNITY; RISK ASSESSMENT; RODENT; TUMOR;

ARTICLE; BONE MARROW; BREAST CANCER; CANCER RISK; CANCER THERAPY; CELL ACTIVITY; HUMAN; IMMUNOCOMPETENT CELL; MACROPHAGE; METASTASIS; MONOCYTE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANTAGONISTS AND INHIBITORS; BREAST NEOPLASMS; FEMALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY;

MUS;

ANIMALS; BREAST NEOPLASMS; CHEMOKINE CCL2; FEMALE; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84924365423     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13931     Document Type: Article

References (12)

1. Wynn, T. A., Chawla, A. & Pollard, J. W. Nature 496, 445-455 (2013).
2. Noy, R. & Pollard, J. W. Immunity 41, 49-61 (2014).
3. DeNardo, D. G. et al. Cancer Discov. 1, 54-67 (2011).
4. Ries, C. H. et al. Cancer Cell 25, 846-859 (2014).
5. Qian, B.-Z. et al. Nature 475, 222-225 (2011).
6. De Palma, M. & Lewis, C. E. Cancer Cell 23, 277-286 (2013).
7. Bonapace, L. et al. Nature 515, 130-133 (2014).
8. Saji, H. et al. Cancer 92, 1085-1091 (2001).
9. Squadrito, M. L. & De Palma, M. Mol. Aspects Med.32, 123-145 (2011).
10. Pienta, K. J. et al. Invest. New Drugs 31, 760-768 (2013).
11. Pahler, J. C. et al. Neoplasia 10, 329-339 (2008).
12. Swierczak, A. et al. Cancer Immunol. Res. 2, 765-776 (2014).